Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EVYD Technology develops healthcare artificial intelligence and big data platforms to enable value-based care, public/population health monitoring, policy insights, and research efficiency. Their flagship product "EVYDENCE" aggregates disparate healthcare data into structured formats to generate actionable insights using machine learning/NLP. They are active in Southeast Asia with collaborations such as the A*STAR-EVYD Joint Lab. Clinical studies include digital therapeutic interventions for type 2 diabetes via national apps like BruHealth. The company achieved ISO/IEC27001 certification in May 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EVYD Technology.